Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA topoisomerase 2 (TOP2) is a critical nuclear enzyme that regulates DNA topology by generating transient double-strand breaks to allow the passage of one DNA duplex through another, a process essential for replication, transcription, and chromosome segregation [2, 4]. The DNA topoisomerase 2-DNA cleavage complex (TOP2cc) is the specific catalytic intermediate where the enzyme is covalently tethered to the 5' ends of the broken DNA [3, 19]. This complex is the primary pharmacological target for 'topoisomerase II poisons' such as etoposide and anthracyclines, which stabilize the TOP2cc and prevent DNA re-ligation [1, 16]. The resulting accumulation of protein-blocked DNA breaks is highly cytotoxic to rapidly dividing cancer cells, making it a cornerstone of various chemotherapy regimens [5, 11]. However, the stabilization of these complexes can also lead to chromosomal translocations and off-target effects, such as cardiotoxicity and secondary leukemias, particularly when the TOP2B isoform is involved [10, 17, 20].
Topoisomerase II poisons stabilize the transient covalent intermediate formed between the enzyme and DNA (the cleavage complex), preventing the re-ligation of the double-strand break. This leads to the accumulation of permanent DNA breaks, which stall replication and transcription machinery, ultimately triggering programmed cell death (apoptosis).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase 2-DNA cleavage complex (TOP2cc).